Last Price
1.40
Today's Change
+0.02 (1.44%)
Day's Change
1.30 - 1.44
Trading Volume
106,586
Overview
Market Cap
2 Million
Shares Outstanding
1 Million
Avg Volume
756,873
Avg Price (50 Days)
2.18
Avg Price (200 Days)
4.60
PE Ratio
-0.91
EPS
-1.54
Earnings Announcement
18-Nov-2024
Previous Close
1.38
Open
1.30
Day's Range
1.3 - 1.44
Year Range
1.032 - 18.36
Trading Volume
106,592
Price Change Highlight
1 Day Change
1.45%
5 Day Change
-4.11%
1 Month Change
-14.11%
3 Month Change
-60.78%
6 Month Change
-59.77%
Ytd Change
-88.67%
1 Year Change
-91.36%
3 Year Change
-97.51%
5 Year Change
-97.51%
10 Year Change
-97.51%
Max Change
-97.51%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
Container Carrier Profits Soar on Record Volumes, Higher Rates
3
CEO Morning Brief
4
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
